Veracyte (VCYT) Total Non-Current Liabilities: 2012-2025
Historic Total Non-Current Liabilities for Veracyte (VCYT) over the last 6 years, with Sep 2025 value amounting to $109.5 million.
- Veracyte's Total Non-Current Liabilities rose 29.24% to $109.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $109.5 million, marking a year-over-year increase of 29.24%. This contributed to the annual value of $123.5 million for FY2024, which is 76.39% up from last year.
- Latest data reveals that Veracyte reported Total Non-Current Liabilities of $109.5 million as of Q3 2025, which was down 10.56% from $122.5 million recorded in Q2 2025.
- Over the past 5 years, Veracyte's Total Non-Current Liabilities peaked at $123.5 million during Q4 2024, and registered a low of $49.1 million during Q1 2021.
- For the 3-year period, Veracyte's Total Non-Current Liabilities averaged around $91.0 million, with its median value being $84.8 million (2024).
- Its Total Non-Current Liabilities has fluctuated over the past 5 years, first spiked by 202.04% in 2021, then fell by 14.01% in 2023.
- Quarterly analysis of 5 years shows Veracyte's Total Non-Current Liabilities stood at $85.6 million in 2021, then fell by 8.02% to $78.7 million in 2022, then fell by 11.06% to $70.0 million in 2023, then surged by 76.39% to $123.5 million in 2024, then climbed by 29.24% to $109.5 million in 2025.
- Its Total Non-Current Liabilities stands at $109.5 million for Q3 2025, versus $122.5 million for Q2 2025 and $119.9 million for Q1 2025.